If you’re reading this, you’ve probably already tried the reasonable things. Therapy. Maybe an SSRI, maybe two. Breathing exercises you were skeptical of and did anyway. And the anxiety is still there, running underneath everything, making ordinary days cost more than they should.
So you started looking for what’s next, and ketamine came up.
Here’s the straight answer. The research on ketamine for anxiety specifically is early and thin. Six controlled studies, about 106 people in total. That’s a fraction of what exists for depression, where a single study enrolled 227 people on its own.
We say that as a program that offers ketamine therapy at our Fort Lauderdale location. We’d rather tell you now than take your money and let you find out.
But there’s a second half to this, and it’s the part that actually helps most people who land on this page.
Anxiety almost never shows up alone
Here’s what we see constantly: someone arrives certain the problem is anxiety, and once we actually look, anxiety turns out to be the loudest symptom rather than the whole picture. Underneath it is often depression, unprocessed trauma, or a substance that started as a way to take the edge off. These things travel together: more than 20 million American adults are living with both a mental health condition and a substance use problem at the same time.
That matters enormously for you, because the evidence for ketamine is far stronger in depression than in anxiety. If depression is part of what’s going on (and for a lot of people with stubborn anxiety, it is), you may be closer to a treatment with real support behind it than this page’s opening suggested.
It’s also worth saying that the line between the two isn’t as clean as the diagnostic categories suggest. Plenty of people describe what they’re feeling as anxiety because anxiety is the part they can name: the racing thoughts, the dread before a phone call, the body that won’t settle. The flatness underneath it gets less airtime because it’s harder to point at, and because it’s easy to mistake for exhaustion or personality.
That’s not a technicality. It’s the difference between spending money on a coin flip and spending it on something the research actually backs. The only way to know which situation you’re in is to have someone look properly, and that’s a conversation, not a questionnaire you fill in before an appointment.
What the anxiety research does and doesn’t show
Here’s the honest summary of those six studies, without the statistics lecture.
The clearest signal was in social anxiety, where people improved meaningfully compared with a placebo. The studies were tiny (one had twelve participants), so while the direction is encouraging, nobody can tell you how big the benefit would be for you. The possible range runs from modest to substantial, and the data can’t narrow it. That’s not a reason to dismiss it. It’s a reason not to bet your savings on it.
For PTSD and OCD, the results didn’t reach significance. In plain terms: the studies couldn’t show ketamine beat a placebo for those conditions.
There’s even less for generalized anxiety, the everyday, always-on kind most people mean. What exists comes from a ten-person subgroup inside a single trial. Ten people isn’t a finding. It’s a hint that someone should run a real study.
| What was studied | How many people | What they found |
|---|---|---|
| Social anxiety | 30, across 2 studies | Better than placebo, but only 30 people |
| Generalized anxiety | 10, inside one study | A hint, not a finding |
| PTSD | 61, across 3 studies | No significant benefit over placebo |
| OCD | 15, in 1 study | No significant benefit over placebo |
Two more things worth knowing. Everything above was measured over hours and days, and the reviews are explicit that there’s no long-term data on safety or effectiveness. Ketamine also produces effects you can feel, which makes these studies hard to blind properly. When people can tell they got the real thing, expectation shapes how they rate their own anxiety.
Later reviews haven’t changed the picture. The most recent one screened more than 4,000 records, included 78 studies, and found only eleven that looked at a primary anxiety disorder. More papers, same conclusion.
What we’d actually do
If you called us tomorrow, we wouldn’t start with a dose. We’d start by figuring out what’s driving this.
That evaluation looks at your history, what you’ve already tried and how it went, your other medications, heart health, sleep, substance use, and whether something other than anxiety sits underneath what you’re feeling. Even the longest follow-up study available, which tracked NIMH trial participants for an average of nine years, could not produce enough long-term outcome data to guide treatment decisions. That’s why who you are matters more here than what the drug does on average, and why having a team that will actually figure that out with you is the whole game.
Sometimes that conversation ends with ketamine on the table, usually when depression is a real part of the picture. Sometimes it ends with a clear “not this, here’s what instead.” Both are good outcomes. The bad outcome is paying for six sessions of something that was never aimed at your actual problem.
If you want that conversation, our Fort Lauderdale team will have it with you before you commit to anything.
If ketamine isn’t the answer, what is?
If ketamine isn’t right for you, you shouldn’t be left choosing between it and nothing. Here’s what the alternatives actually are.
For anxiety that hasn’t responded to a first medication, the usual next steps aren’t exotic. There’s often room to adjust what you’re already on (dose, timing, or a different class entirely) before jumping to something off-label. There’s also structured therapy built specifically for anxiety, which has a deeper evidence base than anything on this page and works differently from general talk therapy. Dialectical behavior therapy is one of the approaches we use. And if trauma is underneath it, trauma-informed treatment addresses the thing generating the anxiety rather than turning down the volume on it. For anxiety that shows up with PTSD, that distinction matters a lot.
None of that is a consolation prize. For a lot of people it’s the thing that finally works, and it’s frustrating how often it gets skipped because it sounds less like a breakthrough.
The goal is the treatment aimed at your actual problem, in the right order, without a detour through something expensive that was never designed for it.
Four questions worth asking any program
Put these to us on the first call, and to anyone else you’re considering.
- Does a psychiatrist do the evaluation, or someone else?
- What does it look at besides the anxiety itself?
- What does it cost, and does insurance apply?
- If you decide ketamine isn’t right for me, what do you recommend instead?
That last one is the tell. A program with a real answer has thought about your situation rather than its calendar.
Common questions
Is ketamine approved for anxiety?
Ketamine’s FDA approval is as an anesthetic, so psychiatric uses are prescribed off-label. That’s a routine category, and one psychiatry relies on constantly: the FDA’s position is that providers generally may prescribe an approved drug for an unapproved use when they judge it medically appropriate. Off-label status isn’t the real caution here, though. The thing to weigh for anxiety is that the underlying evidence is still thin, which is a separate question from what’s printed on the label.
Does ketamine work for anxiety?
The honest answer is case by case, depending on the patient medical history. But six small studies found a promising signal in social anxiety and no clear benefit in PTSD or OCD. That’s early evidence, not a track record.
What if my anxiety comes with depression?
Then you’re in a much better position, because the depression research is substantial. This is the most common scenario we see, and the one where ketamine most often makes sense. Worth getting evaluated rather than guessing.
Will insurance pay for it?
Coverage varies by plan, so it’s worth having someone check your benefits rather than trusting any clinic’s website, including ours.
Is this the same as Spravato?
No. Spravato (esketamine) is an FDA-approved nasal spray for treatment-resistant depression with its own federal safety program. IV ketamine for anxiety is a different, off-label use without that approval.
Living with anxiety that hasn’t responded to the usual things is exhausting in a specific way: you look fine, you function, and nobody can see what it’s costing you. You should get a real answer about what will help.
If ketamine turns out to be part of it, we offer it. If it doesn’t, we’ll say so and point you somewhere better. Either way, start with how we approach anxiety treatment, or just call and tell us what’s been going on.
